EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects

Nakyung Oh, Van Ngu Trinh iD

Cells · 15.05.2026 · 15 (10) · 910

DOI: 10.3390/cells15100910 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 15.05.2026. Verfasst von Nakyung Oh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Tumor Microenvironment, Neoplastic Stem Cells, Immunotherapy, Neoplasms. Die Arbeit nennt 380 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer stem cells (CSCs) are a distinct subpopulation within a tumor that play an important role in tumor initiation, metastasis, therapeutic resistance, and cancer relapse. Their persistence is strongly influenced by the tumor microenvironment (TME), which provides a range of biological signals that maintain stemness, promote immune evasion, and resistance to cancer treatment. Therefore, effective targeting of CSCs is essential to improve therapeutic efficacy. In this review, we summarize the key characteristics of CSCs and their niche within the TME, emphasizing their interactions with immune cells, stromal components, and secreted factors. We also discuss the major challenges in targeting CSCs, including immune evasion, metabolic constraints, and intratumoral heterogeneity. We further highlight current and emerging immunotherapeutic strategies targeting CSCs, including immune checkpoint inhibitors, cancer vaccines, monoclonal antibodies, nanobodies, bispecific antibodies, antibody-drug conjugates (ADCs), CAR-T and CAR-NK cell therapies, oncolytic viruses, as well as innovative approaches such as targeted protein degradation. Finally, we emphasize the importance of a combinatorial approach that integrates CSCs targeting with modulation of the TME. Together, these strategies may lead to more durable responses, enhance therapy efficacy and reduce the risk of tumor recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNeoplastic Stem CellsImmunotherapyNeoplasmsHumansAnimals

Stichwörter der Autor:innen

CAR-NKCAR-Tantibody-drug conjugates (ADCs)bispecific antibodycancer stem cellscancer vaccinesimmune checkpoint inhibitorsimmunotherapymonoclonal antibodynanobodiestumor microenvironment

Autor:innen und Institutionen

  • Department of Epigenetics and Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
  • Center for Translational Cancer Research, Institute of Biosciences and Technology, Texas A&M University, Houston, TX 77030, USA.

ORCID-Profile: Van Ngu Trinh

Zitieren

APA

Oh, N., & Trinh, V. N. (2026). Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects. Cells, 15(10), 910. https://doi.org/10.3390/cells15100910

Vancouver

Oh N, Trinh VN. Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects. Cells. 2026;15(10):910. doi:10.3390/cells15100910

BibTeX
@article{Oh2026,
  author = {Oh, Nakyung and Trinh, Van Ngu},
  title = {Advances in Immunotherapies for Targeting Cancer Stem Cells in a Tumor Microenvironment: Emerging Strategies and Clinical Prospects},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {10},
  pages = {910},
  doi = {10.3390/cells15100910}
}
Kostenlos starten →